of the alcohol functional group. 10 Herein we report a simple and mild Pd(II)-catalyzed method for the efficient construction of the tetrahydro-2H-indeno-[2,1-b]furan framework from acyclic hydroxyalkenes bearing unactivated arenes.
We began our study by subjecting 4-methyl-3-phenylpent-4-en-1-ol (2a) to a catalytic amount of palladium acetate and a variety of different stoichiometric oxidants. Several common combinations for Pd(II)-catalyzed oxidative C-H activations such as Pd(II)/Cu(II), Pd(II)/Ag(I) and Pd(II)/PIDA were shown to be ineffective for this transformation (Table 1 , entries 1-3). 8, 11 Simple Pd(OAc) 2 /pyridine/O 2 (1 atm) system, 12 however, was able to efficiently catalyze the desired transformation, affording 3a in moderate yield (entry 5). The use of bidentate pyridine-based ligands were found to significantly retard the reaction (entries 6, 7). 13 Tuning the substituents on the pyridine ligand (entries 8-10) led to the identification of ethyl nicotinate 14 as the optimal ligand. The ligand loading could also be lowered to 6 mol% without loss of yield (entry 12).
A variety of α-aryl-γ-hydroxyalkenes could be cyclized to the corresponding tetrahydro-2H-indeno-[2,1-b]furan derivatives using this Pd(II)-catalyzed intramolecular tandem oxypalladation/C-H activation protocol. Illustrative examples of the reaction scope are shown in Table 2 . Both alkyl and aryl substituents on the carbon-carbon double bond were tolerated (3b, 3c), as well as tertiary alcohol nucleophile (3d). In addition, a wide range of electron-rich, -neutral and -deficient arenes were found to participate in the C-H activation process (3e-h, 3j). An aryl bromide-containing substrate afforded the desired product (3i) in modest yield, although additional quantities of copper(II) chloride proved to be necessary, 15 this observed orthogonal reactivity relative to the Pd(0)-catalyzed crosscoupling chemistry is useful for the further elaboration of the arene ring. meta-Substituted arene (entry 10) cyclized to give a 3:1 mixture of regioisomers favoring the cleavage of the less hindered C-H bond (3j, 3j'). Finally it was found that a pyridyl group could also participate in the C-H activation process with functionalization solely at the 4-position (3k).
(1) Lactone 4 can be accessed by one step oxidation of the oxyarylation adduct 3a (eq. 1). The relative stereochemistry of 4 was confirmed by X-ray diffraction. Lactone 4 is also structurally related to a class of sulindac-derived biologically active molecules which have been used for "precancerous treatment." 16 To gain an insight into the reaction mechanism, deuterium labeling experiments were performed. The observed kinetic isotope effect for both intermolecular and intramolecular cases were found to be approximately 2. 17 This observation is consistent with a reaction mechanism in which irreversible C-H bond cleavage is rate-limiting. Next, treating 2a with palladium acetate under an argon atmosphere in the presence of ethyl nicotinate also afforded cyclization product 3a (Scheme 2). The formation of 3a in the absence of external re-oxidant is consistent with the Pd(II)/Pd(0) catalytic cycle depicted in Scheme 1.
One of the most interesting aspects of the Pd(II)-catalyzed oxidative process is its orthogonal reactivity compared with Pd(0)-catalyzed transformations (Scheme 3). Treating hydroxyalkene 2i with a catalytic amount of palladium acetate and XPhos in the presence of K 2 CO 3 afforded chroman derivative 5 by a classic Pd(0)-catalyzed C-O coupling. 18 The alkene functional group remained intact. However, switching the base to NaOtBu resulted in the formation of cyclization product 3a via Pd(0)-catalyzed carboetherification of the alkene originally developed by Wolfe and co-workers. 5 On the other hand, subjecting 2i to the standard conditions described in this work led to exclusive formation of 3i via the desired Pd(II)-catalyzed oxypalladation/C-H functionalization pathway. Dechlorinated material was not detected. This demonstrates the potential of diversified modification of a single compound containing multiple functional groups using different palladium catalyst systems.
In conclusion, we have developed an efficient protocol for the intramolecular oxidative oxyarylation of hydroxyalkenes using a Pd(II)-catalyzed tandem oxypalladation/C-H functionalization strategy. This methodology allows rapid access to tetrahydro-2H-indeno-[2,1-b]furan framework from simple acyclic hydroxyalkene bearing unactivated arenes or heteroarenes. Further mechanistic studies and application of this strategy to the synthesis of other heterocyclic systems are currently under investigation.
Experimental Section
An oven-dried 50 mL Schlenk tube equipped with a Teflon-coated magnetic stir bar was charged with palladium acetate (5.6 mg, 0.05 equiv.), potassium carbonate (34.5 mg, 0.5 equiv.). The tube was then briefly evacuated and backfilled with oxygen (This sequence was repeated a total of four times). Ethyl nicotinate (4.5 mg, 0.06 equiv.) and hydroxyalkene (0.50 mmol, 1.0 equiv.) were added to the tube followed by anhydrous toluene (5.0 mL) via syringe. The sealed tube was placed in a pre-heated 100 °C oil bath. After stirring at the same temperature for 19 h the mixture was allowed to cool to room temperature. Ether (5 mL), methanol (0.25 mL), and sodium borohydride (9.5 mg, 0.5 equiv.) were then added and the resulting mixture was stirred for a further 5 min at room temperature. The mixture was then filtered through a short plug of silica gel and concentrated in vacuo. The residue was purified by silica gel flash column chromatography (EtOAc/hexane) to afford the cyclization product.
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Scheme 1.
Scope of the Pd(II)/Pd(0) catalyzed oxidative carboetherification.
Scheme 2.
Oxyarylation in the absence of external oxidant. h.
[b] GC Yield using dodecane as an internal standard.
[c] Without Pd(OAc) 2 . h.
[b] Isolated yields, average of two runs.
[c] With 5 mol% CuCl 2 as co-oxidant and 30 mol% ethyl nicotinate.
